Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board
Former CEO of Freeline Therapeutics, Ltd. has outstanding international drug development, commercialization expertise, with focus on rare disease, gene therapy  

See more here